Skip to main navigation Skip to search Skip to main content

Preliminary analysis into the molecular mechanism of proprietary cancer/COVID-19 drug binding to its major protein target

Project: Research

Project Details

StatusFinished
Effective start/end date1/03/22 → 31/03/23

Funding

  • Noxopharm Limited

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint